Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome

Medicin og biovidenskab

• Congenital Myasthenic Syndromes 100%
• Protein-Tyrosine Kinases 57%
• Ephedrine 28%
• Albuterol 25%
• Cholinesterase Inhibitors 24%
• 2,4-diaminopyridine 15%
• Amifampridine 11%
• Therapeutics 10%
• Muscle Fatigue 8%
• Myasthenia Gravis 8%
• Muscle Weakness 7%
• Drug Combinations 7%
• Age of Onset 6%
• Publications 5%
• PubMed 5%
• Databases 4%
• Mutation 3%
• Pharmaceutical Preparations 2%